Florida Senate - 2024                                     SB 672
       
       
        
       By Senator Calatayud
       
       
       
       
       
       38-00604-24                                            2024672__
    1                        A bill to be entitled                      
    2         An act relating to intravenous vitamin treatment;
    3         providing a short title; creating s. 456.0302, F.S.;
    4         defining the terms “health care provider” and
    5         “intravenous vitamin treatment”; specifying
    6         requirements for health care providers administering
    7         intravenous vitamin treatment; requiring the Board of
    8         Nursing, the Board of Medicine, and the Board of
    9         Osteopathic Medicine to adopt rules establishing
   10         procedures to administer intravenous vitamin treatment
   11         and emergency protocols; providing for disciplinary
   12         action for violations of the act; providing an
   13         effective date.
   14          
   15  Be It Enacted by the Legislature of the State of Florida:
   16  
   17         Section 1. This act may be cited as the “Stephanie Balais
   18  Act.”
   19         Section 2. Section 456.0302, Florida Statutes, is created
   20  to read:
   21         456.0302 Administering intravenous vitamin treatment.—
   22         (1) As used in this section, the term:
   23         (a) “Health care provider” means a person licensed under
   24  chapter 458, chapter 459, or chapter 464.
   25         (b) “Intravenous vitamin treatment” means a procedure in
   26  which high concentrations of vitamins and minerals are
   27  administered directly into a person’s bloodstream, allowing
   28  rapid absorption of higher doses of the vitamins and minerals
   29  than if received through food or supplements.
   30         (2) A health care provider administering intravenous
   31  vitamin treatment shall:
   32         (a) Obtain a complete self-screening risk assessment
   33  questionnaire from a patient before administering an intravenous
   34  vitamin treatment. The health care provider must use a form
   35  adopted by rule by the applicable board.
   36         (b) Provide a patient with information related to potential
   37  side effects and risks of intravenous vitamin treatment and
   38  instructions on when to seek medical attention.
   39         (c) Provide a patient with a visit summary.
   40         (d) Notify a patient’s designated physician that an
   41  intravenous vitamin treatment was administered.
   42         (e) Have a written plan for the provision of emergency
   43  care. A copy of the emergency plan must be kept at the location
   44  offering intravenous vitamin treatment. The plan must include
   45  all of the following:
   46         1. The name and address of the hospital closest to the
   47  location at which the intravenous vitamin treatment is being
   48  administered.
   49         2. Reasons for which an emergency transfer of a patient may
   50  be required.
   51         3. Medical services to be used in the event of a health
   52  emergency.
   53         (3) A health care provider may not administer intravenous
   54  vitamin treatment to a patient if the provider determines that
   55  it is unsafe to administer such treatment based upon the results
   56  of the self-screening risk assessment questionnaire or
   57  otherwise.
   58         (4) The respective boards shall adopt rules establishing
   59  procedures to safely administer intravenous vitamin treatment
   60  and establish protocols to follow in the event of a health
   61  emergency, including, but not limited to, requirements for:
   62         (a) Education and training for health care providers
   63  authorized to administer intravenous vitamin treatment.
   64         (b) Self-screening risk assessments.
   65         (c) Information that a health care provider must provide to
   66  a patient before administering an intravenous vitamin treatment.
   67         (d) Documentation regarding the process of administering
   68  intravenous vitamin treatment.
   69         (e) Notification that must be provided to a patient’s
   70  designated physician if an intravenous vitamin treatment is
   71  administered.
   72         (f) Evaluation and review of the administration practices
   73  used to administer intravenous vitamin treatment.
   74         (5) A violation of this section constitutes grounds for
   75  disciplinary action under this chapter and chapter 458, chapter
   76  459, or chapter 464, as applicable.
   77         Section 3. This act shall take effect July 1, 2024.